Clinical trial
A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat…
NCT00349492 · Clinical Research Center for Solid Tumor, Korea, Other · Completed
Key facts
| NCT number | NCT00349492 |
|---|---|
| Title | A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer |
| Official title | Randomized, Phase III Trial Comparing Etoposide/Cisplatin (EP) With Irinotecan/Cisplatin (IP) in Patients With Previously Untreated, Extensive Disease (ED) Small Cell Lung Cancer (SCLC) |
| Lead sponsor | Clinical Research Center for Solid Tumor, Korea, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | IP |
| Enrollment | 372 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Oct 1, 2013 |
| First posted | Jul 7, 2006 |
| Last update posted | Dec 4, 2013 |
| Countries | South Korea |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: